The SS18-SSX fusion oncoprotein: Friend and foe in targeted therapy for synovial sarcoma
Oncology Research · 2025 · 33 (5) · 1001-1005
DOI: 10.32604/or.2025.060573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2025. Verfasst von Gavin M Anchondo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Jacksonville State University, Jacksonville, AL 36265, USA. Hauptthemen laut MEDLINE: Sarcoma, Synovial, Oncogene Proteins, Fusion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Synovial sarcoma is a high-grade soft tissue malignancy characterized by a unique fusion gene known as SS18-SSX. The SS18-SSX fusion protein acts as an oncogenic driver of synovial sarcoma, and it has thus been commonly accepted that disruption of SS18-SSX function represents a therapeutic means of treating synovial sarcoma, but emerging evidence suggests that upon depletion of SS18-SSX, an anti-apoptotic signal surprisingly arises to protect synovial sarcoma cell survival. In this article, we discuss the controversial roles of SS18-SSX's transcriptional activity in synovial sarcoma biology and outline a synergistic strategy for overcoming the resistance of synovial sarcoma cells to SS18-SSX targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Jacksonville State University, Jacksonville, AL 36265, USA.
Zitieren
APA
Anchondo, G. M., Parker, K., Bruce, A., Cortez, E., & Su, L. E. (2025). The SS18-SSX fusion oncoprotein: Friend and foe in targeted therapy for synovial sarcoma. Oncology Research, 33(5), 1001-1005. https://doi.org/10.32604/or.2025.060573
Vancouver
Anchondo GM, Parker K, Bruce A, Cortez E, Su LE. The SS18-SSX fusion oncoprotein: Friend and foe in targeted therapy for synovial sarcoma. Oncology Research. 2025;33(5):1001-1005. doi:10.32604/or.2025.060573
BibTeX
@article{Anchondo2025,
author = {Anchondo, Gavin M and Parker, Kyra and Bruce, Alexis and Cortez, Elizabeth and Su, L E},
title = {The SS18-SSX fusion oncoprotein: Friend and foe in targeted therapy for synovial sarcoma},
journal = {Oncology Research},
year = {2025},
volume = {33},
number = {5},
pages = {1001--1005},
doi = {10.32604/or.2025.060573}
}
EUVIMED